Bioreactors Market Research Methodology: Business Plans, Inventive Technology, Growth Factors

Publisher: The Insight Partners

A bioreactor is a device or system engineered or manufactured to support biologically active environment. These are vessels in which a chemical processes involving organisms or biochemically active substances derived from such organisms are carried out. The increasing adoption of single-use bioreactors, and rapid growth of the pharmaceuticals and biotechnology industries are among the prime factors driving the bioreactors market. Additionally, increasing number of technology and distribution collaborations is anticipated to drive the market growth in the coming years. However, stringent government regulations hamper the growth of the market. The developing healthcare infrastructure and increasing investments by biopharmaceutical companies are projected generate lucrative opportunities for the growth of the market.

The global bioreactors market, based on molecule, is segmented into monoclonal antibodies, vaccines, recombinant proteins, stem cells, gene therapy, and others. The monoclonal antibodies segment held the largest share of the market in 2019. However, stem cell segment is estimated to register the highest CAGR in the market during the forecast period.

Request for sample PDF copy at: https://www.theinsightpartners.com/sample/TIPHE100000880/

The growth of the bioreactors market is attributed to the increasing research and development activities and rising number of biochemical processes across various domains. Leading companies operating in the bioreactors market are Thermo Fisher Scientific Inc., Applikon Biotechnology BV, Merck KGaA, Sartorius AG, PBS Biotech, Inc., General Electric, Bioengineering AG, Cellexus, Danaher (Pall Corporation), and bbi-biotech GmbH, among others.

The biopharmaceuticals market is increasing. The strong demand for biologics and biosimilars has driven the growth of the industry. The biopharmaceutical industry is one of the most significant contributors to the economy. The US is the largest market for biopharmaceuticals and leader in biopharmaceutical R&D. As per the Pharmaceutical Research and Manufacturers Association (PhRMA), the US firms conduct over half the world's R&D in pharmaceuticals (US$ 75 billion) and hold the highest number of patents in new medicines. Besides development economies, there have been rapid growth witnesses in the research environment in emerging economies such as Brazil, China, and India. Factors such as increasing biologics approval, growing biosimilar pipeline, and increasing investment in research activities are prime factors facilitating the growth of the industry.

Moreover, biopharmaceutical research activities are gaining pace in emerging economies such as Brazil, China, and India, and offering lucrative opportunities for the growth of the market. Apart from this, increasing approvals in gene and cell therapies are favoring the growth of the market. The approved gene therapies are Glybera-used to treat Lipoprotein Lipase Deficiency, and Strimvelis- treating ADA-Severe Combined Immuno Deficiency.

Molecule Insights

Based on molecule, the bioreactors market is segmented into monoclonal antibodies, vaccines, recombinant proteins, stem cells, gene therapy, and others. The monoclonal antibodies segment held the largest share of the market in 2019. However, the stem cells segment is estimated to register the highest CAGR in the market during the forecast period.

Technology Insights

Based on technology, the bioreactors market is segmented into wave-induced motion SUB, stirred SUB, single-use bubble column, and others. In 2019, the wave-induced motion SUB segment held the largest share of the market. Increasing research and development spending across the globe on drug development are projected to drive the growth of the market for this segment during the forecast period. However, the stirred SUB technology segment is likely to register the highest CAGR during the forecast period.

End User Insights

Based on end user, the bioreactors market is segmented into research and development organizations, biopharma manufacturers, and contract manufacturing organizations (CMOs). In 2019, biopharma manufacturers segment held the largest share of the market. The segment is also expected to register the fastest CAGR during the forecast period, and the projected growth of the market for this segment is ascribed to the increasing adoption of bioreactors in biopharmaceuticals manufacturing plants.

The report segments global bioreactors market as follows:

Global Bioreactors Market – By Cell

• Mammalian Cells
• Bacterial Cells
• Yeast Cells
• Others

Global Bioreactors Market – By Molecule

• Monoclonal Antibodies
• Vaccines
• Recombinant Proteins
• Stem Cells
• Gene Therapy
• Others

Global Bioreactors Market – By Technology

• Wave-Induced Motion SUB
• Stirred SUB
• Single-Use Bubble Column
• Others

Global Bioreactors Market – By End User

• Research and Development Organizations
• Biopharma Manufacturers
• Contract Manufacturing Organizations (CMOs)

Purchase Copy of This Report at:  https://www.theinsightpartners.com/buy/TIPHE100000880/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.  

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com